BMX-001: New Therapy Showing Increased Survival in Newly Diagnosed Glioblastoma

Time: 12:15 pm
day: Conference Day One


  • New drug class – redox-active metallaporphyrins – positioned to transform the efficacy of radiation and chemotherapy in oncology
  • Novel BMX-001 dual action enhances tumor killing while mitigating radiation-induced side-effects
  • Discussion of ongoing randomized, 160 patient, multi-center trial